Wikidata

(Q63805830)

English

A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata

clinical trial

In more languages

Statements

short name
BRAVE-AA2 (English)
0 references
title
A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata (English)
0 references
medical condition
alopecia
0 references
alopecia areata
0 references
country
Argentina
0 references
Australia
0 references
Brazil
0 references
Israel
0 references
Japan
0 references
Taiwan
0 references
start time
1 July 2019
0 references
end time
12 May 2021
0 references
number of participants
476
0 references
minimum age
18 year
0 references
maximum age
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63805830&oldid=2130943270"